Belite Bio, Inc (BLTE)

NASDAQ: BLTE · Real-Time Price · USD

167.02

+1.59 (0.96%)

Apr 21, 2026, 1:58 PM EDT - Market open

Belite Bio Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 21, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	6,571	6,001	1,948	1,263	750	-
Market Cap Growth	217.88%	207.98%	54.32%	68.44%	-	-
Enterprise Value	6,016	5,726	1,861	1,221	701	-
Last Close Price	165.43	159.96	63.10	45.75	30.14	-
PB Ratio	8.45	7.79	13.36	13.96	18.06	-
P/TBV Ratio	8.45	7.79	13.37	13.96	18.06	-
Debt / Equity Ratio	0.00	0.00	0.00	0.01	0.02	-
Net Debt / Equity Ratio	-0.64	-0.64	-0.99	-0.96	-0.99	-1.04
Net Debt / EBITDA Ratio	5.86	5.86	3.63	2.77	3.23	1.78
Net Debt / FCF Ratio	13.24	13.24	4.93	2.92	3.48	2.30
Quick Ratio	49.90	49.90	24.09	24.50	20.01	10.61
Current Ratio	50.02	50.02	24.31	24.76	20.35	10.66
Return on Equity (ROE)	-16.94%	-16.94%	-30.60%	-47.95%	-43.45%	-46.60%
Return on Assets (ROA)	-11.29%	-11.29%	-20.26%	-28.50%	-25.59%	-27.78%
Return on Capital Employed (ROCE)	-10.90%	-10.90%	-27.40%	-34.80%	-30.40%	-58.60%
Earnings Yield	-1.19%	-1.29%	-1.85%	-2.50%	-1.69%	-
FCF Yield	-0.57%	-0.62%	-1.51%	-2.37%	-1.58%	-
Buyback Yield / Dilution	-9.82%	-9.82%	-14.83%	-33.12%	-108.74%	-8.87%

Updated Mar 2, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q